EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 206 / Numéro 3 (2012) Biologie Aujourd'hui, 206 3 (2012) 191-203 Références
Accès gratuit
Numéro
Biologie Aujourd'hui
Volume 206, Numéro 3, 2012
Page(s) 191 - 203
DOI https://doi.org/10.1051/jbio/2012018
Publié en ligne 22 novembre 2012
  • Abulrob A., Sprong H., Bergen en Henegouwen P.V., Stanimirovic D., The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. J Neurochem, 2005, 95, 1201–1214. [CrossRef] [PubMed] [Google Scholar]
  • Allen D.D., Lockman P.R., Roder K.E., Dwoskin L.P., Crooks P.A., Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter. J Pharmacol Exp Ther, 2003, 304, 1268–1274. [CrossRef] [PubMed] [Google Scholar]
  • Atwal J.K., Chen Y., Chiu C., Mortensen D.L., Meilandt W.J., Liu Y., Heise C.E., Hoyte K., Luk W., Lu Y., Peng K., Wu P., Rouge L., Zhang Y., Lazarus R.A., Scearce-Levie K., Wang W., Wu Y., Tessier-Lavigne M., Watts R.J., A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo. Sci Transl Med, 2011, 3, 84ra43. [CrossRef] [PubMed] [Google Scholar]
  • Benchenane K., Bérézowski V., Ali C., Fernández-Monreal M., López-Atalaya J.P., Brillault J., Chuquet J., Nouvelot A., MacKenzie E.T., Bu G., Cecchelli R., Touzani O., Vivien D., Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor – related protein – mediated transcytosis. Circulation, 2005, 111, 2241–2249. [CrossRef] [PubMed] [Google Scholar]
  • Bertrand Y., Currie J.-C., Demeule M., Régina A., Ché C., Abulrob A., Fatehi D., Sartelet H., Gabathuler R., Castaigne J.-P., Stanimirovic D., Béliveau R., Transport Characteristics of a Novel Peptide Platform for CNS Therapeutics. J Cell Mol Med, 2010, 14, 2827–2839 [CrossRef] [PubMed] [Google Scholar]
  • Boado R.J., Zhang Y., Wang Y., Pardridge W.M., GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier. Biotech Bioeng, 2008, 100, 387–396. [CrossRef] [Google Scholar]
  • Breedveld P., Beijnen J.H., Schellens J.H., Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol Sci, 2006, 27, 17–24. [CrossRef] [PubMed] [Google Scholar]
  • Brownlees J., Williams C.H., Peptidases peptides, and the mammalian blood-brain barrier. J Neurochem, 1993, 60, 1089–1096. [CrossRef] [Google Scholar]
  • Bu G., Maksymovitch, E.A., Nerbonne, J.M., Schwartz, A.L., Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem, 1994, 269, 18521–18528. [PubMed] [Google Scholar]
  • Cam J.A., Bu G., Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family. Mol Neurodegener, 2006, 1, 8. [CrossRef] [PubMed] [Google Scholar]
  • Coloma M.J., Lee H.J., Kurihara A., Landaw E.M., Boado R.J., Morrison S.L., Pardridge W.M., Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res, 2000, 17, 266–274. [CrossRef] [PubMed] [Google Scholar]
  • De Boer A.G., Gaillard P.J., Drug targeting to the brain. Annu Rev Pharmacol Toxicol, 2007, 47, 323–355. [CrossRef] [PubMed] [Google Scholar]
  • Demeule M., Poirier J., Jodoin J., Bertrand Y., Desrosiers R.R., Dagenais C., Nguyen T., Lanthier J., Gabathuler R., Kennard M., Jefferies W.A., Karkan D., Tsai S., Fenart L., Cecchelli R., Béliveau R., High transcytosis of melanotransferrin (p97) across the blood-brain barrier. J Neurochem, 2002, 83, 924–933. [CrossRef] [PubMed] [Google Scholar]
  • Demeule M., Bertrand Y., Michaud-Levesque J., Jodoin J., Rolland Y., Gabathuler R., Béliveau R., Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration. Blood, 2003, 102, 1723–1731. [CrossRef] [PubMed] [Google Scholar]
  • Demeule M., Currie J.-C., Bertrand Y., Ché C., Nguyen T., Régina A., Gabathuler R., Castaigne J.P., Béliveau R., Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2. J Neurochem, 2008a, 106, 1534–1544. [CrossRef] [PubMed] [Google Scholar]
  • Demeule M., Régina A., Ché C., Poirier J., Nguyen T., Gabathuler R., Castaigne J.P., Béliveau R. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther, 2008b, 324, 1064–1072. [CrossRef] [Google Scholar]
  • Donoso M., Cancino J., Lee J., van Kerkhof P., Retamal C., Bu G., Gonzalez A., Cáceres A., Marzolo M.P., Polarized traffic of LRP1 involves AP1B and SNX17 operating on Y-dependent sorting motifs in different pathways. Mol Biol Cell, 2009, 20, 481–497. [CrossRef] [PubMed] [Google Scholar]
  • Food M., Rothenberger S., Gabathuler R., Haidl I.D., Reid G., Jefferies, W.A., Transport and expression in human melanomas of a transferrin like glycosylphosphatidylinositol-anchored proteins. J Biol Chem, 1994, 269, 3034–3040. [PubMed] [Google Scholar]
  • Gabathuler R., Blood-brain barrier transport of drugs for the treatment of brain diseases. CNS and Neurol Dis-Drug Targets, 2009, 8, 195–294. [CrossRef] [Google Scholar]
  • Gabathuler R., Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis, 2010, 37, 48–57. [CrossRef] [PubMed] [Google Scholar]
  • Gabathuler R., Arthur G., Kennard M.L., Chen Q., Tsai S., Yang J., Schoorl W., Vitalis T., Jefferies W.A., Development of a potential protein vector (NeuroTrans) to deliver drugs across the blood-brain barrier. In de Boer A.G. (Ed.), Drug Transport(ers) and the Diseased Brain, Int Congress Series, Esteve Foundation Symposium XI, S’Agaró (Girona), Spain, Elsevier 1277, 2005, pp. 171–184. [Google Scholar]
  • Gaillard P.J., Leyssen P., Appeldoorn C., Dorland R., van Kregten J., Manca M.F., Johan Neyts J., Development of brain-targeted liposomes with antiviral drugs for treating lethal viral encephalitis. Presented at: 8th Cerebral Vascular Biology (CVB), 2009 International Conference. Sendai, Japan, 28 June–2 July 2009. [Google Scholar]
  • Hertz J., Strickland D.K., LRP: a multifunctional scavenger and signalling receptor. J Clin Invest, 2001, 108, 779–784. [PubMed] [Google Scholar]
  • Jefferies W.A., Food M., Gabathuler R., Rothenberger S., Yamada T., McGeer P.L., Reactive microglia specifically associated with amyloid plaques in Alzheimer’s disease brain tissue express melanotransferrin. Brain Res, 1996, 712, 122–126. [CrossRef] [PubMed] [Google Scholar]
  • Karkan D., Pfeifer C., Vitalis T.Z., Arthur G., Ujiie M., Chen Q., Tsai S., Koliatis G., Gabathuler R., Jefferies W.A., A unique carrier for delivery of therapeutical compounds beyond the blood-brain barrier. PloS One, 2008, 3, e2469. [CrossRef] [PubMed] [Google Scholar]
  • Kounnas M.Z., Moir R.D., Rebeck G.W., Bush A.I., Argraves W.S., Tanzi R.E., Hyman B.T., Strickland D.K., LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell, 1995, 82, 331–340. [CrossRef] [PubMed] [Google Scholar]
  • Li Y., Marzolo M.P., van Kerkhof P., Strous G.J., Bu G., The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein. J Biol Chem, 2000, 275, 17187–17194. [CrossRef] [PubMed] [Google Scholar]
  • Migliorini M.M., Behre E.H., Brew S., Ingham K.C., Strickland D.K., Allosteric modulation of ligand binding to low density lipoprotein receptor-related protein by the receptor-associated protein requires critical lysine residues within the carboxy-terminal domain. J Biol Chem, 2003, 278, 17986–17992. [CrossRef] [PubMed] [Google Scholar]
  • Misra A., Ganesh S., Shahiwala A., Shah S.P., Drug Delivery to the Central Nervous System: a Review. J Pharm Pharmaceut Sci, 2003, 6, 252–273. [Google Scholar]
  • Moestrup S.K., Gliemann J., Pallesen G., Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res, 1992, 269, 375–342. [CrossRef] [PubMed] [Google Scholar]
  • Moroo I., Ujiie M., Walker B.L., Tiong J.W., Vitalis T.Z., Karkan D., Gabathuler R., Moise A.R., Jefferies W.A., Identification of a novel route of iron transcytosis across the mammalian blood-brain barrier. Microcirculation, 2003, 10, 457–462. [PubMed] [Google Scholar]
  • Muruganandam A., Tanha J., Narang S., Stanimirovic D., Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. FASEB J, 2002, 16, 240–242. [PubMed] [Google Scholar]
  • Pan W., Kastin A.J., Zankel T.C., van Kerkhof P., Terasaki T., Bu G., Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier. J Cell Sci, 2004, 117, 5071–5078. [CrossRef] [PubMed] [Google Scholar]
  • Pardridge W.M., Drug Targeting to the Brain. Pharma Res, 2007a, 24, 1733–1744. [CrossRef] [Google Scholar]
  • Pardridge W.M., shRNA and siRNA delivery to the brain. Adv Drug Delivery Rev, 2007b, 59, 141–152. [CrossRef] [Google Scholar]
  • Pardridge W.M., Biopharmaceutical drug targeting to the brain. J Drug Target, 2010, 18, 157–167. [CrossRef] [PubMed] [Google Scholar]
  • Paulusma C.C., Folmer D.E., Ho-Mok K.S., de Waart D.R., Hilarius P.M., Verhoeven A.J., Oude Elferink R.P., ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology, 2008, 47, 268–278. [CrossRef] [PubMed] [Google Scholar]
  • Prince W.S., McCormick L.M., Wendt D.J., Fitzpatrick, P.A., Schwartz K.L., Aguilera A.I., Koppaka V., Christianson T.M., Vellard M.C., Pavloff N., Lemontt J.F., Qin M., Starr C.M., Bu G., Zankel T.C., Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and α-L-iduronidase or acid α-glucosidase. J Biol Chem, 2004, 279, 35037–35046. [CrossRef] [PubMed] [Google Scholar]
  • Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T., Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions. Neuron, 1993, 11, 575–580. [CrossRef] [PubMed] [Google Scholar]
  • Regina A., Demeule M., Che C., Lavallee I., Poirier J., Gabathuler R., Beliveau R., Castaigne J.-P., Antitumor activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol, 2008, 155, 185–197 [CrossRef] [PubMed] [Google Scholar]
  • Spencer B.J., Verma I.M., Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci USA, 2007, 104, 7594–7599. [CrossRef] [Google Scholar]
  • Tang Y., Han T., Everts M., Zhu Z.B., Gillespie G.Y., Curiel D.T., Wu H., Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model. Gene Therapy, 2007, 14, 523–532. [CrossRef] [PubMed] [Google Scholar]
  • Tanha J., Dubuc G., Hirama T., Narang S.A., MacKenzie C.R., Selection by phage display of llama conventional VH fragments with heavy chain antibody VHH properties. J Immunol Meth, 2002, 263, 97–109. [CrossRef] [Google Scholar]
  • Tanha J., Muruganandam A., Stanimirovic D., Phage display technology for identifying specific antigens on brain endothelial cells. Meth Mol Med, 2003, 89, 435–449. [Google Scholar]
  • Thomas F.C., Taskar K., Rudraraju V., Goda S., Thorsheim H.R., Gaasch J.A., Mittapalli R.K., Palmieri D., Steeg P.S., Lockman P.R., Smith Q.R., Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharma Res, 2009, 26, 2486–2494. [CrossRef] [Google Scholar]
  • Wolf G.G., Lopes M.B.S., VandenBerg S.R., Gonias S.L., Characterization and immunohistochemical localization of α2-macroglobulin receptor (Low-density lipoprotein receptor-related protein) in human brain. Am J Pathol, 1992, 141, 37–42. [PubMed] [Google Scholar]
  • Yamamoto M., Ikeda K., Ohshima K., Tsugu H., Kimura H., Tomonaga M., Increased expression of Low Density Lipoprotein Receptor-related protein/α2-macroglobulin receptor in human malignant astrocytomas. Cancer Res, 1997, 57, 2799–2805. [PubMed] [Google Scholar]
  • Yu Y.J., Zhang Y., Kenrich M., Hoyte K., Luk W., Lu Y., Atwal J., Elliott J.M., Prabhu S., Watts R.J., Dennis M.S., Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med, 2011, 3, 84ra44. [Google Scholar]
  • Zensi A., Begley D., Pontikis C., Legros C., Mihoreanu L., Wagner S., Büchel C., von Briesen H., Kreuter J., Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Contr Rel, 2009, 137, 78–86. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.